Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colon Cancer Stage”

3,267 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,267 results

Early research (Phase 1)Study completedNCT00433576
What this trial is testing

Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumStage I Colon Cancer+5 more
National Cancer Institute (NCI) 20
Early research (Phase 1)Study completedNCT00685568
What this trial is testing

Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous Polyposis

Who this might be right for
Colorectal CancerPrecancerous Condition
M.D. Anderson Cancer Center 22
Not applicableStudy completedNCT03707574
What this trial is testing

Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study

Who this might be right for
Advanced Malignant NeoplasmAdvanced MelanomaAdvanced Renal Cell Carcinoma+51 more
National Cancer Institute (NCI) 64
Testing effectiveness (Phase 2)Study completedNCT02138617
What this trial is testing

Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal Cancer

Who this might be right for
Colon Cancer
UNC Lineberger Comprehensive Cancer Center 100
Early research (Phase 1)Ended earlyNCT03275974
What this trial is testing

Glutamine PET Imaging Colorectal Cancer

Who this might be right for
RAS Wild TypeStage IV Colorectal CancerStage IVA Colorectal Cancer+1 more
M.D. Anderson Cancer Center 6
Testing effectiveness (Phase 2)Ended earlyNCT02842580
What this trial is testing

De-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Federation Francophone de Cancerologie Digestive 21
Not applicableStudy completedNCT00410579
What this trial is testing

Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers

Who this might be right for
Colorectal CancerFatigueLong-term Effects Secondary to Cancer Therapy in Adults+2 more
NSABP Foundation Inc 744
Large-scale testing (Phase 3)Study completedNCT03306394
What this trial is testing

Trifluridine/Tipiracil (Also Known as S 95005 or TAS-102) in Patients With a Pretreated Colorectal Cancer That Has Spread (Metastatic).

Who this might be right for
Metastatic Colorectal Cancer
Institut de Recherches Internationales Servier 907
Large-scale testing (Phase 3)Study completedNCT00384176
What this trial is testing

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX

Who this might be right for
Colorectal Cancer
AstraZeneca 1,814
Testing effectiveness (Phase 2)Study completedNCT00025350
What this trial is testing

Gefitinib in Treating Patients With Recurrent Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT02103062
What this trial is testing

Phase 2 Study With Abraxane (Nab®Paclitaxel) in Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Celgene 41
Not applicableStudy completedNCT04898842
What this trial is testing

Feasibility Study of a 4 Stage Bowel Obstruction Cancer Diet

Who this might be right for
Colorectal CancerColorectal NeoplasmsColorectal Carcinoma+8 more
Royal Surrey County Hospital NHS Foundation Trust 30
Large-scale testing (Phase 3)Ended earlyNCT03970694
What this trial is testing

Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Chemotherapy For Unresectable Locally Advanced Colon Cancer

Who this might be right for
Colon Cancer
Sun Yat-sen University 49
Early research (Phase 1)Study completedNCT05014360
What this trial is testing

JNJ-64251330 in Participants With Familial Adenomatous Polyposis

Who this might be right for
Adenomatous Polyposis Coli
Janssen Research & Development, LLC 42
Early research (Phase 1)Study completedNCT00291486
What this trial is testing

Capecitabine and 131I-huA33 in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Ludwig Institute for Cancer Research 19
Testing effectiveness (Phase 2)Ended earlyNCT03099486
What this trial is testing

Regorafenib Plus 5-Fluorouracil/Leucovorin Beyond Progression in mCRC

Who this might be right for
Colorectal Cancer
Fox Chase Cancer Center 2
Testing effectiveness (Phase 2)Study completedNCT00613080
What this trial is testing

Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer

Who this might be right for
Colorectal Cancer
Radiation Therapy Oncology Group 79
Testing effectiveness (Phase 2)Study completedNCT01006369
What this trial is testing

Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Rutgers, The State University of New Jersey 38
Not applicableLooking for participantsNCT05334069
What this trial is testing

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAnn Arbor Stage I Lymphoma+59 more
Alliance for Clinical Trials in Oncology 2,000
Testing effectiveness (Phase 2)Study completedNCT01409005
What this trial is testing

Gemcitabine-UFTE Chemotherapy in Refractory Colorectal Cancer

Who this might be right for
Metastatic or Recurrent Colorectal CancerRefractory to Fluoropyrimidine, Oxaliplatin and IrinotecanSalvage Chemotherapy
Seoul National University Bundang Hospital 41
Next Page